Neil Allan Johnson Insider Profile

4 Followers
Neil Allan Johnson, Chief Executive Officer at Duke Capital, holds 330.00K shares in Marvel Biosciences Corp (Ticker: TSE:MRVL), holds 7.42M shares in Duke Capital (Ticker: GB:DUKE), holds 875.00K shares in Thiogenesis Therapeutics Corp (Ticker: TSE:TTI). Most recently, Neil Allan Johnson Bought ― shares of Marvel Biosciences Corp on Aug 21, 2024 for an estimated value of 5.50K.
tipranks
Neil Allan Johnson

Neil Allan Johnson
Duke Capital (DUKE)
Chief Executive Officer

Ranked #69,930 out of 98,834 Corporate Insiders

Profitable Transactions

46%
6 out of 13 Profitable Transactions

Average Return

-7.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
58.88%
26.03%
14.30%
0.79%
A breakdown of Neil Allan Johnson's holdings

Insider Roles

Duke Capital
(DUKE)
Chief Executive Officer
Canaccord Genuity
(CCORF)
Senior Officer
Thiogenesis Therapeutics Corp
(TTI)
Executive, Ten Percent Owner
Marvel Biosciences Corp
(MRVL)
Director
Roles that Neil Allan Johnson holds in companies

Most Profitable Insider Trade

Stock:
Duke Capital
(DUKE)
Rating:Informative Buy
Date:Oct 09, 2017 - Oct 09, 2018
Return:+18.90%
The most profitable trade made by Neil Allan Johnson

Neil Allan Johnson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Duke Capital
Aug 01, 2024
Chief Executive Officer
Uninformative Buy
£2.45M
DCF
Difference Cap Financial
Apr 16, 2014
Informative Buy
93.75K
C$2.61M
Canaccord Genuity
Mar 30, 2012
Senior Officer
Uninformative Buy
1.98K
$1.08M
Marvel Biosciences Corp
Aug 21, 2024
Director
Informative Buy
5.50K
C$33.00K
Thiogenesis Therapeutics Corp
Apr 01, 2022
Executive, Ten Percent Owner
Uninformative Sell
12.50K
C$595.00K
List of latest transactions for each holding click on a transaction to see Neil Allan Johnson's performance on stock

Neil Allan Johnson insider profile FAQ

What is the percentage of profitable transactions made by Neil Allan Johnson?
The percentage of profitable transactions made by Neil Allan Johnson is 46%.
    What is the average return per transaction made by Neil Allan Johnson?
    The average return per transaction made by Neil Allan Johnson is -7.40%.
      What stocks does Neil Allan Johnson hold?
      Neil Allan Johnson holds: GB:DUKE, TSE:DCF, CCORF, TSE:MRVL, TSE:TTI stocks.
        What was Neil Allan Johnson’s latest transaction?
        Neil Allan Johnson latest transaction was an Informative Buy of C$5.50K.
          What was Neil Allan Johnson's most profitable transaction?
          Neil Allan Johnson’s most profitable transaction was an Informative Buy of GB:DUKE stock on October 9, 2017. The return on the trade was 18.90%.
            What is Neil Allan Johnson's role in Duke Capital?
            Neil Allan Johnson's role in Duke Capital is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.